Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 3/20 | 0.36 |
| ▸ | NOS2 | P35228 | 3/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | SELE | P16581 | 1/20 | 0.33 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.30 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL9053689 | 0.92 | HRH4 (0.45) | HRH4CYP1A2POLBNOS3NOS2 | |
| SCHEMBL4872734 | 0.87 | CYP1A2 (0.37) | HRH4CYP1A2POLBNOS3NOS2 | |
| SCHEMBL805489 | 0.84 | — | — | |
| SCHEMBL1767853 | 0.83 | HRH4 (0.34) | HRH4CYP1A2POLBSELEVCAM1 | |
| SCHEMBL20801088 | 0.83 | NOS3 (0.37) | HRH4CYP1A2POLBNOS3NOS2 | |
| SCHEMBL25986789 | 0.83 | HRH4 (0.34) | HRH4CYP1A2POLBAAK1 | |
| SCHEMBL12311620 | 0.82 | — | — | |
| SCHEMBL792959 | 0.82 | — | — | |
| SCHEMBL9610942 | 0.82 | — | — | |
| SCHEMBL16030878 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10622919-B2 | Nano-porous thin film, methods of fabricating thereof and triboelectric generator using the same | UNIVERSITY-INDUSTRY FOUNDATION (UIF), YONSEI UNIVERSITY (KR) | 2020-04-14 | — | — | US | claimed |
| US-10619054-B2 | Porous layer, low-reflective coating layer, optical member, and methods of fabricating the porous layer | UNIVERSITY-INDUSTRY FOUNDATION (UIF), YONSEI UNIVERSITY (KR) | 2020-04-14 | — | — | US | claimed |
| EP-2736113-B1 | LITHIUM SECONDARY BATTERY | LG CHEMICAL LTD (KR) | 2019-10-09 | — | — | EP | claimed |
| US-20180294745-A1 | NANO-POROUS THIN FILM, METHODS OF FABRICATING THEREOF AND TRIBOELECTRIC GENERATOR USING THE SAME | UNIVERSITY-INDUSTRY FOUNDATION (UIF), YONSEI UNIVERSITY (KR) | 2018-10-11 | — | — | US | claimed |
| EP-2736112-B1 | NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING SAME | LG CHEMICAL LTD (KR) | 2018-02-21 | — | — | EP | claimed |
| US-20170355860-A1 | POROUS LAYER, LOW-REFLECTIVE COATING LAYER, OPTICAL MEMBER, AND METHODS OF FABRICATING THE POROUS LAYER | UNIVERSITY-INDUSTRY FOUNDATION (UIF), YONSEI UNIVERSITY (KR) | 2017-12-14 | — | — | US | claimed |
| CN-103718372-B | Nonaqueous electrolyte and lithium secondary battery using the same | 株式会社LG化学 | 2016-12-14 | — | — | CN | claimed |
| CN-103733415-B | Nonaqueous electrolyte and lithium secondary battery using same | 株式会社LG化学 | 2016-09-14 | — | — | CN | claimed |
| EP-2736112-A2 | NONAQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING SAME | LG Chem, Ltd. (KR) | 2014-05-28 | — | — | EP | claimed |
| EP-2736113-A2 | NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING SAME | LG Chem, Ltd. (KR) | 2014-05-28 | — | — | EP | claimed |
| CN-103733415-A | Nonaqueous electrolyte and lithium secondary battery using same | LG CHEMICAL LTD | 2014-04-16 | — | — | CN | claimed |
| US-20130252113-A1 | NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING THE SAME | LG CHEM, LTD. (KR) | 2013-09-26 | — | — | US | claimed |
| US-20130244120-A1 | Non-Aqueous Electrolyte And Lithium Secondary Battery Using The Same | LG CHEM, LTD. (KR) | 2013-09-19 | — | — | US | claimed |
| US-20250338410-A1 | ELECTRONIC DEVICE INCLUDING FLEXIBLE DISPLAY AND DISPLAY SUPPORT STRUCTURE, AND MANUFACTURING METHOD OF DISPLAY SUPPORT STRUCTURE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-10-30 | — | — | US | disclosed |
| US-11276825-B2 | Organic molecules for use in organic devices | CYNORA GMBH (DE) | 2022-03-15 | — | — | US | disclosed |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| US-20090069305-A1 | Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-03-12 | — | — | US | disclosed |
| US-20080261921-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| US-7420056-B2 | Substituted bicyclic imidazo-3-ylamine compounds | GRUENENTHAL GMBH (DE) | 2008-09-02 | — | — | US | disclosed |
| US-20070155965-A1 | SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS | GRUENENTHAL GMBH. (DE) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069305-A1 | Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor | HRH4, HRH3, HRH2 | HRH4 1/4885CYP1A2 2697/4885POLB 4593/4885 |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | CHRM1, C1S, DNMT3L | HRH4 685/4885CYP1A2 188/4885POLB 726/4885 |
| US-20070155965-A1 | SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS | AADAC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAICS | HRH4 9/4885CYP1A2 250/4885POLB 2896/4885 |
| US-20080261921-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | MAP3K20, MAP3K19, MAP4K2 | HRH4 2089/4885CYP1A2 3975/4885POLB 2427/4885 |
| US-11276825-B2 | Organic molecules for use in organic devices | AOX1, OR10J3, L1CAM | HRH4 2550/4885CYP1A2 43/4885POLB 733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.